The genetic abnormality in the beta cell determines the response to an oral glucose load

Diabetologia

Volumn 45, Issue 3, 2002, Pages 427-435

  Stride, A ^a   Vaxillaire, M ^b   Tuomi, T ^c   Barbetti, F ^d   Njolstad P R ^e   Hansen, T ^f   Costa, A ^g   Conget, I ^g   Pedersen, O ^f   Sovik O ^e   Lorini, R ^h   Groop, L ⁱ   Froguel, P ^b   Hattersley, A T ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b INSTITUT PASTEUR DE LILLE   (France)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d IBCIT Biomedical Science Park   (Italy)

^e UNIVERSITY OF BERGEN   (Norway)

^f STENO DIABETES CENTER   (Denmark)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetics; Glucokinase; Hepatocyte nuclear factor 1 alpha; Maturity onset diabetes of the young; MODY; Oral glucose tolerance test

Indexed keywords

GLUCOKINASE; GLUCOSE; INSULIN; NUCLEAR FACTOR I;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC DISORDER; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FASTING; FEMALE; GLUCOKINASE; GLUCOSE TOLERANCE TEST; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTES; HUMANS; KINETICS; MALE; MUTATION; NUCLEAR PROTEINS; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0036210337     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0770-9     Document Type: Article

References (38)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation
3. Impact of new diagnostic criteria for diabetes on different populations
4. Diabetes in older adults: Comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification
5. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiology data
6. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey. 1988-1994
7. Cardiovascular risk profile in individuals with borderline glycaemia: The effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World health Organization Provisional Report
8. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
9. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
10. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta
11. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
12. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20
13. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on Chromosome 12
14. Insulin resistance as the major cause of impaired glucose tolerance: A self-fulfilling prophesy?
15. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
16. Beta-cell genes and diabetes: Molecular and clinical characteristics of mutations in transcription factors
17. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q
18. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families
19. Early-onset diabetes linked to chromosome 12 (MODY3) is characterised by a severe insulin secretion defect
20. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes
21. Insulin secretion and insulin sensitivity in diabetic subgroups: Studies in the prediabetic and diabetic state
22. Three novel missense mutations in the glucokinase gene (G80S; E221 K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY)
23. MODY 2 presenting as neonatal hyperglycemia: A need to re-shape the definition of "neonatal diabetes"?
24. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI
25. A missense mutation, Val62Ala, in the glucokinase gene in a Norwegian family with maturity-onset diabetes of the young
26. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta
27. Novel MODY3 Mutations in the Hepatic Nuclear Factor-1α Gene: Evidence for a hyperexcitability of pancreatic B-cells to intravenous secretagogues in a glucose tolerant carrier of a P447L mutation
28. Mutations in the hepatocyte nuclear factor-1 a gene in Caucasian families originally classified as having Type 1 diabetes
29. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families
30. Follow up of a HNF-1 alpha mutant carrier with a severely impaired beta cell function
31. Assessment of immunoassays for insulin in diagnostic tests for insulinoma
32. Establishing a standard definition for child overweight and obesity worldwide: International survey
33. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
34. Clinical characteristics of subjects with a missense mutation in glucokinase
35. Glucokinase deficiency results in beta-cell disorder characterised by normal fasting plasma proinsulin concentrations
36. Unravelling the heterogeneity of Type 2 diabetes
37. MODY 2 presenting as neonatal hyperglycaemia: A need to reshape the definition of "neonatal diabetes"?
38. Characterisation of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect